Alpha-1 Biologics Corporation (A1Bio)

Alpha-1 Biologics Corporation (A1Bio) was founded in June, 2011 to develop products for immune cell replenishment (pre- and post-cancer therapy, HIV/AIDS), HDL and LDL regulation (cardiovascular disease), and diagnostic testing (CD4 enumeration, leukemia).

 

Suresh Anaganti, Ph.D.CEO
Mail Box 107
T: 631-338-5163
F: 631-444-8825